146 related articles for article (PubMed ID: 10696897)
1. Concurrent expressions of metallothionein, glutathione S-transferase-pi, and P-glycoprotein in colorectal cancers.
Sutoh I; Kohno H; Nakashima Y; Hishikawa Y; Tabara H; Tachibana M; Kubota H; Nagasue N
Dis Colon Rectum; 2000 Feb; 43(2):221-32. PubMed ID: 10696897
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.
Okada D; Kawamoto M; Koizumi K; Tanaka S; Fukuda Y
Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):272-6. PubMed ID: 12892456
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer.
Monden N; Abe S; Sutoh I; Hishikawa Y; Kinugasa S; Nagasue N
Oncology; 1997; 54(5):391-9. PubMed ID: 9260601
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
6. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
Zhang F; Qi L; Chen H
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
[TBL] [Abstract][Full Text] [Related]
7. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
Kutlik MT; Ayhan A; Göğüş S; Yalçin B; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2002; 19(5):337-45. PubMed ID: 12078865
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of metallothionein and drug-resistance in bladder cancer.
Saika T; Tsushima T; Ochi J; Akebi N; Nasu Y; Matsumura Y; Ohmori H
Int J Urol; 1994 Jun; 1(2):135-9. PubMed ID: 7627849
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.
Mulder TP; Verspaget HW; Sier CF; Roelofs HM; Ganesh S; Griffioen G; Peters WH
Cancer Res; 1995 Jun; 55(12):2696-702. PubMed ID: 7780987
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
14. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
15. Expression of drug resistance gene products during progression of lung carcinomas.
Mattern J; Koomägi R; Volm M
Oncol Rep; 2002; 9(6):1181-4. PubMed ID: 12375015
[TBL] [Abstract][Full Text] [Related]
16. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma.
Zhang Z; Deng X; Ren X; Zhang B; Chen X; Yang J; Ding H; Sui J; Song X
Scand J Gastroenterol; 2010 Aug; 45(7-8):925-34. PubMed ID: 20377486
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
18. Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery.
Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
Oncol Rep; 2001; 8(4):815-9. PubMed ID: 11410790
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.
Harpole DH; Moore MB; Herndon JE; Aloia T; D'Amico TA; Sporn T; Parr A; Linoila I; Allegra C
Clin Cancer Res; 2001 Mar; 7(3):562-9. PubMed ID: 11297249
[TBL] [Abstract][Full Text] [Related]
20. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
